{"id":"https://openalex.org/W2016691199","doi":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","title":"Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double\u2010blind, placebo\u2010controlled trial with an open\u2010label, long\u2010term extension study","display_name":"Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double\u2010blind, placebo\u2010controlled trial with an open\u2010label, long\u2010term extension study","publication_year":2012,"publication_date":"2012-07-12","ids":{"openalex":"https://openalex.org/W2016691199","doi":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","mag":"2016691199","pmid":"https://pubmed.ncbi.nlm.nih.gov/24843617","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4015431"},"language":"en","primary_location":{"id":"doi:10.1111/j.2040-1124.2012.00226.x","doi":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2012.00226.x","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2012.00226.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052412166","display_name":"Yutaka Seino","orcid":"https://orcid.org/0000-0002-1099-7989","observed_orcids":["https://orcid.org/0000-0002-1099-7989"]},"institutions":[{"id":"https://openalex.org/I2800996768","display_name":"Kansai Electric Power (Japan)","ror":"https://ror.org/03xrg8731","country_code":"JP","type":"company","lineage":["https://openalex.org/I2800996768"]},{"id":"https://openalex.org/I4210123101","display_name":"Kansai Electric Power Hospital","ror":"https://ror.org/02srt1z47","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123101"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yutaka Seino","raw_affiliation_strings":["Kansai Electric Power Hospital Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kansai Electric Power Hospital Osaka Japan","institution_ids":["https://openalex.org/I2800996768","https://openalex.org/I4210123101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090544866","display_name":"Shinzo Hiroi","orcid":"https://orcid.org/0000-0002-0015-4793","observed_orcids":["https://orcid.org/0000-0002-0015-4793"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinzo Hiroi","raw_affiliation_strings":["Takeda Pharmaceutical Company Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Osaka Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010302035","display_name":"Masashi Hirayama","orcid":"https://orcid.org/0009-0008-6217-167X","observed_orcids":["https://orcid.org/0009-0008-6217-167X"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Hirayama","raw_affiliation_strings":["Takeda Pharmaceutical Company Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceutical Company Osaka Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036190568","display_name":"Kohei Kaku","orcid":"https://orcid.org/0000-0003-1574-0565","observed_orcids":["https://orcid.org/0000-0003-1574-0565"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kohei Kaku","raw_affiliation_strings":["Kawasaki Medical School, Okayama Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kawasaki Medical School, Okayama Japan","institution_ids":["https://openalex.org/I189996419"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5052412166"],"corresponding_institution_ids":["https://openalex.org/I2800996768","https://openalex.org/I4210123101"],"apc_list":{"value":3850,"currency":"USD","value_usd":3850},"apc_paid":null,"fwci":2.6773,"has_fulltext":true,"cited_by_count":36,"citation_normalized_percentile":{"value":0.89472982,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"3","issue":"6","first_page":"517","last_page":"525"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9049999713897705},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.7319999933242798},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8859999775886536},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9430000185966492},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9480000138282776},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.7239999771118164},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.746999979019165},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8240000009536743},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.4580000042915344},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.9368588924407959},{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.9347861409187317},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9160561561584473},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7160289883613586},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6205115914344788},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5412483215332031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.524266242980957},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.45258012413978577},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4349023401737213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43471741676330566},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.4264865219593048},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3894227147102356},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.20250001549720764},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.12215238809585571},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.10421115159988403},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1111/j.2040-1124.2012.00226.x","doi":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2012.00226.x","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3001436","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4015431","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24843617","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24843617","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of diabetes investigation","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4015431","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4015431/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Diabetes Investig","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.2040-1124.2012.00226.x","doi":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.2040-1124.2012.00226.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2012.00226.x","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016691199.pdf","grobid_xml":"https://content.openalex.org/works/W2016691199.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W43308025","https://openalex.org/W91242618","https://openalex.org/W1485176679","https://openalex.org/W1569365382","https://openalex.org/W1582261481","https://openalex.org/W1776821951","https://openalex.org/W1968736342","https://openalex.org/W1969932276","https://openalex.org/W1975588287","https://openalex.org/W2009392873","https://openalex.org/W2020267609","https://openalex.org/W2022430914","https://openalex.org/W2032254224","https://openalex.org/W2059245135","https://openalex.org/W2061865937","https://openalex.org/W2082354988","https://openalex.org/W2086842286","https://openalex.org/W2092918268","https://openalex.org/W2097395605","https://openalex.org/W2104053168","https://openalex.org/W2106036385","https://openalex.org/W2106154942","https://openalex.org/W2132062386","https://openalex.org/W2141946042","https://openalex.org/W2145661125","https://openalex.org/W2169274492","https://openalex.org/W2172502596","https://openalex.org/W2320312654","https://openalex.org/W2341918383"],"related_works":["https://openalex.org/W7096120565","https://openalex.org/W2118701488","https://openalex.org/W2092918268","https://openalex.org/W3210417240","https://openalex.org/W2104053168","https://openalex.org/W1968736342","https://openalex.org/W1925960178","https://openalex.org/W2086842286","https://openalex.org/W2061865937","https://openalex.org/W2560313462"],"abstract_inverted_index":{"AIMS/INTRODUCTION:":[0],"To":[1],"evaluate":[2],"the":[3,86,92,189,192,200,204],"efficacy":[4,90],"and":[5,25,63,89,117,132,148,153,175,216],"safety":[6,88],"of":[7,91,167,194,206],"alogliptin":[8,30,176,213],"added":[9,43],"to":[10,44,225],"treatment":[11,60,114],"with":[12,37,50,61,102,108,140,156,179,203,230,255],"glimepiride.":[13],"MATERIALS":[14],"AND":[15],"METHODS:":[16],"This":[17,251],"multicenter,":[18],"randomized,":[19],"double-blind,":[20],"parallel-group,":[21],"24-week":[22],"(12-week":[23],"observation":[24],"12-week":[26],"treatment)":[27],"study":[28,84,258,262],"compared":[29,107,155],"12.5":[31,96,131],"or":[32,97],"25":[33,98,133],"mg":[34,99,134],"in":[35,47,74,100,186,227],"combination":[36,101,125,135,177,201],"glimepiride":[38,45,103,109,128,157,173,226],"(1-4":[39],"mg/day)":[40],"vs":[41,127],"placebo":[42],"monotherapy":[46,110,158,174],"Japanese":[48,228],"patients":[49,229],"type":[51,231],"2":[52,232],"diabetes":[53,233],"who":[54,234],"had":[55,235],"poor":[56],"glycemic":[57,237],"control":[58,238],"despite":[59],"diet":[62],"exercise":[64],"plus":[65,241],"a":[66,72],"sulfonylurea.":[67],"The":[68,165],"primary":[69],"end-point":[70],"was":[71,137,170,197,214,253],"change":[73],"glycated":[75],"hemoglobin":[76],"(HbA1c)":[77],"from":[78],"baseline.":[79],"A":[80],"40-week":[81],"open-label":[82],"extension":[83,190],"evaluated":[85],"long-term":[87,261],"combination.":[93],"RESULTS:":[94],"Alogliptin":[95,130],"significantly":[104,141],"decreased":[105],"HbA1c":[106,150,162],"after":[111],"12":[112],"weeks'":[113],"(-0.59,":[115],"-0.65":[116],"0.35%,":[118],"respectively;":[119],"P":[120],"<":[121],"0.0001":[122],"for":[123,248],"both":[124],"groups":[126],"monotherapy).":[129],"therapy":[136,224],"also":[138],"associated":[139],"higher":[142],"responder":[143],"rates":[144],"(HbA1c":[145,159],"<6.9%:":[146,160],"9.6%":[147],"7.7%,":[149],"<7.4%:":[151,163],"29.8%":[152],"34.6%)":[154],"0%,":[161],"3.9%).":[164],"incidence":[166,193],"adverse":[168,182,195,207],"events":[169,183,196,208],"comparable":[171,198],"between":[172,199],"treatment,":[178],"most":[180],"reported":[181],"being":[184,209],"mild":[185],"severity.":[187],"In":[188],"study,":[191],"groups,":[202],"majority":[205],"mild.":[210],"CONCLUSIONS:":[211],"Once-daily":[212],"effective":[215],"generally":[217],"well":[218],"tolerated":[219],"when":[220],"given":[221],"as":[222],"add-on":[223],"inadequate":[236],"on":[239],"sulfonylurea":[240],"lifestyle":[242],"measures.":[243],"Clinical":[244],"benefits":[245],"were":[246],"maintained":[247],"52":[249],"weeks.":[250],"trial":[252],"registered":[254],"ClinicalTrials.gov":[256],"(double-blind":[257],"no.":[259,263],"NCT01318083;":[260],"NCT01318135).":[264]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}